Literature DB >> 17965844

[Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)].

S Nitschmann1, G Schultze-Werninghaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965844     DOI: 10.1007/s00108-007-1964-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

1.  Treating COPD--the TORCH trial, P values, and the Dodo.

Authors:  Klaus F Rabe
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

2.  Prevention of death in COPD.

Authors:  Peter J Barnes
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245

3.  Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Authors:  Peter Kardos; Marion Wencker; Thomas Glaab; Claus Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

4.  Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.

Authors:  Marc Decramer; Bartolome Celli; Donald P Tashkin; Romain A Pauwels; Deborah Burkhart; Cara Cassino; Steven Kesten
Journal:  COPD       Date:  2004       Impact factor: 2.409

5.  The TORCH (towards a revolution in COPD health) survival study protocol.

Authors:  J Vestbo
Journal:  Eur Respir J       Date:  2004-08       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.